Question

A 59-year-old with newly diagnosed HFrEF (EF 25%), NYHA II, BP 122/74, K⁺ 4.6, eGFR 55, no contraindications. Which initial disease-modifying regimen best aligns with guideline-directed therapy?

Accepted Answer

Sacubitril/valsartan plus carvedilol, spironolactone, and dapagliflozin

Answer

Lisinopril plus metoprolol tartrate only

Answer

Furosemide and isosorbide mononitrate

Answer

Verapamil and empagliflozin

Answer

Ivabradine and digoxin

Practice question

A 59-year-old with newly diagnosed HFrEF (EF 25%), NYHA II, BP 122/74, K⁺ 4.6, eGFR 55, no contraindications. Which initial disease-modifying regimen best aligns with guideline-directed therapy?